Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Sana Biotechnology Inc (NASDAQ: SANA) closed at $6.86 in the last session, up 7.86% from day before closing price of $6.36. In other words, the price has increased by $7.86 from its previous closing price. On the day, 6.8 million shares were traded. SANA stock price reached its highest trading level at $7.4 during the session, while it also had its lowest trading level at $6.43.
Ratios:
We take a closer look at SANA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.07 and its Current Ratio is at 6.07. In the meantime, Its Debt-to-Equity ratio is 0.28 whereas as Long-Term Debt/Eq ratio is at 0.25.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on June 26, 2024, initiated with a Buy rating and assigned the stock a target price of $16.
On January 16, 2024, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $12.
On September 25, 2023, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $9.JMP Securities initiated its Mkt Outperform rating on September 25, 2023, with a $9 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 08 ’24 when Yang Patrick Y sold 25,000 shares for $9.45 per share. The transaction valued at 236,300 led to the insider holds 149,250 shares of the business.
NELSEN ROBERT bought 1,818,181 shares of SANA for $9,999,996 on Feb 08 ’24. The Director now owns 12,446,022 shares after completing the transaction at $5.50 per share. On Feb 08 ’24, another insider, ARCH Venture Fund X, L.P., who serves as the 10% Owner of the company, bought 1,818,181 shares for $5.50 each. As a result, the insider paid 9,999,996 and bolstered with 12,446,022 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SANA now has a Market Capitalization of 1519510656 and an Enterprise Value of 1314516992.
Stock Price History:
The Beta on a monthly basis for SANA is 1.48, which has changed by 0.14715719 over the last 52 weeks, in comparison to a change of 0.24125004 over the same period for the S&P500. Over the past 52 weeks, SANA has reached a high of $12.00, while it has fallen to a 52-week low of $2.74. The 50-Day Moving Average of the stock is -3.42%, while the 200-Day Moving Average is calculated to be 9.11%.
Shares Statistics:
According to the various share statistics, SANA traded on average about 1.89M shares per day over the past 3-months and 1900850 shares per day over the past 10 days. A total of 197.86M shares are outstanding, with a floating share count of 120.52M. Insiders hold about 45.59% of the company’s shares, while institutions hold 50.28% stake in the company. Shares short for SANA as of 1719532800 were 26013419 with a Short Ratio of 13.74, compared to 1717113600 on 25025474. Therefore, it implies a Short% of Shares Outstanding of 26013419 and a Short% of Float of 24.490000000000002.
